LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
20 hedge funds and large institutions have $4.63M invested in Landos Biopharma, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.
Holders
20
Holders Change
-3
Holders Change %
-13.04%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$25.7K |
| 2 |
WAM
2
Warberg Asset Management
Winnetka,
Illinois
|
$21.9K |
| 3 |
3
BlackRock
New York
|
$10.1K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$1.87K |
| 5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$6K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
JPMorgan Chase & Co
New York
| $0 | 611 | – | – |
|
27
Acadian Asset Management
Boston,
Massachusetts
| $0 | 1,344 | – | – |
|